Although glibenclamide has been shown to increase the production of type-I IFN from human monocytes against Mycobacterium species9,10, little is known about the effect of glibenclamide on IFN-α production following influenza vaccination in people with T2DM, and further studies will be required to determine this effect. The gene discussed is IFNA1; the disease is type 2 diabetes mellitus.